Diabetic retinopathy (DR), DR screening, proliferative diabetic retinopathy (PDR), nonproliferative diabetic retinopathy (NPDR), diabetic macular edema (DME), Imaging
Andrew A. Moshfeghi, MD, MBA
Associate Professor of Clinical Ophthalmology
Medical Director of the USC Roski Eye Institute
Director of Clinical Trials
Director of the Vitreoretinal Surgery Fellowship Program
Director of the Medical Retina Fellowship Program
Los Angeles, CA
Andrew A. Moshfeghi, MD, MBA, earned his medical degree from Tulane University School of Medicine in 1999. Following completion of his residency in ophthalmology, Dr. Moshfeghi attended the prestigious Bascom Palmer Eye Institute for his fellowship training in medial retina and vitreoretinal surgery and diseases. He also graduated from the University of Miami Graduate School of Business Administration with an MBA specializing in Health Sector Policy and Management.
Dr. Andrew A. Moshfeghi serves as an associate professor of clinical ophthalmology, director of Clinical Trials, and director of the Medical Retina and Surgical Retina Fellowship Programs at USC. He is a recognized expert in diseases of the vitreous, retina, and macula. He formerly served as associate professor of Ophthalmology and medical director at the Bascom Palmer Eye Institute at the University of Miami. Dr. Moshfeghi is a noted vitreoretinal surgeon.
Dilsher Dhoot, MD
California Retina Consultants/Retina Consultants of America
Santa Barbara, CA
Dr. Dilsher S. Dhoot was raised in California and received his undergraduate degree with Honors from the University of California, Berkeley. He went on to complete his medical degree at Oregon Health Science University in Portland, Oregon. Dr. Dhoot remained in Portland for his residency training in ophthalmology at the renowned Casey Eye Institute. After completing his residency, Dr. Dhoot pursued fellowship training in vitreoretinal surgery at the Cleveland Clinic, Cole Eye Institute. The Cleveland Clinic is a global leader in medical innovation and care and is consistently ranked as one of the top hospitals and ophthalmology programs in the world.
Dr. Dhoot has been honored with several awards during his career including the Honor Award from the American Society of Retina Specialists. Dr. Dhoot has presented his research and lectured at national and international conferences. He has also published numerous book chapters and research articles in several journals including Ophthalmology, the British Journal of Ophthalmology, Retina, Eye, and Ophthalmic Surgery, Lasers & Imaging. He currently serves as a section editor for the Retina Times and is also a peer reviewer for several journals. Dr. Dhoot is actively involved in the education of vitreoretinal fellows in his role as an Adjunct Clinical Assistant Professor of Ophthalmology at the Keck School of Medicine, USC.
Dr. Dhoot has been involved in clinical research for many years. Recently, he has been an investigator in clinical research trials for the treatment of age-related macular degeneration, retinal vein occlusion, and diabetic retinopathy. Dr. Dhoot is a Board Certified Ophthalmologist and is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, and the American Society of Retina Specialists. He has also been elected to the prestigious Retina Society.
David Eichenbaum, MD
Clinical Assistant Professor
Department of Ophthalmology
University of South Florida College of Medicine
Retina Vitreous Associates of Florida
Dr. Eichenbaum is a board certified ophthalmologist, fellowship-trained in diseases and surgery of the vitreous and retina. He is a partner and Director of Research at Retina Vitreous Associates of Florida, a multi-MD sub-specialty vitreoretinal private practice and has been in practice since 2007. He completed the Medical Honors Program at the University of South Florida, earning his undergraduate and medical degree in Tampa. He completed his Ophthalmology residency at the University of South Florida, where he served as Chief Resident, and completed his two-year Surgical Retina fellowship at Tufts New England Eye Center and Ophthalmic Consultants of Boston.
Dr. Eichenbaum has served as Principal Investigator in over 40 Phase 1 though Phase 4 clinical trials, has published in numerous professional journals, published multiple textbook chapters, and has presented his work at the American Society of Retinal Specialists, American Academy of Ophthalmology, and the Association of Research and Vision in Ophthalmology meeting. He moderates at the Vit-Buckle Society and teaches nationally through both CME and commercial formats, lecturing on clinical science as well as common retinal diseases such as macular degeneration, diabetic eye disease, retinal vascular occlusions. Dr. Eichenbaum serves on numerous Clinical and Scientific Advisory Boards, and serves on National Executive Steering Committees for both commercial and pipeline products.
Dr. Eichenbaum is a Fellow of the American Academy of Ophthalmology, sits on the Board of the Florida Society of Ophthalmology, serves as Vice President of Education for the Florida Society of Ophthalmology, and has served as Past President of the Tampa Bay Ophthalmic Society. In 2015, he received Michael R. Redmond, MD Outstanding Young Ophthalmologist Award from the Florida Society of Ophthalmology..
Dr. Eichenbaum is appointed as a Collaborative Associate Professor of Ophthalmology at the University of South Florida Morsani College of Medicine and co-chairs a monthly retina conference for the Ophthalmology department with his partners.
Avni P. Finn, MD
Northern California Retina Vitreous Associates
Mountain view, CA
Dr. Finn was born in London, but moved to the United States at a young age, growing up in Claremont, California. She earned a Bachelor of Arts in Human Biology from Stanford University and also minored in Spanish. She graduated Phi Beta Kappa and a member of the Cap and Gown Women's Honor Society. Dr. Finn then went on to pursue both her medical degree and a business degree at the Dartmouth School of Medicine and the Tuck School of Business in Hanover, New Hampshire.
Dr. Finn completed her ophthalmology residency at the Massachusetts Eye and Ear Infirmary at Harvard Medical School in Boston, Massachusetts. While in residency she received the Gragoudas Prize for her clinical research. She also was a recipient of the Heed Ophthalmic Foundation Fellowship, awarded nationally to top clinical residents in ophthalmology.
Dr. Finn then performed a fellowship in medical and surgical diseases of the retina and vitreous at Duke University in Durham, North Carolina. During fellowship, she received the Ronald G. Michels Fellowship Foundation award, given select outstanding fellows in vitreoretinal surgery.
Dr. Finn is board certified by the American Board of Ophthalmology. She has published numerous original research articles on a wide variety of retinal diseases including new techniques for macular hole surgery, the use of intraoperative OCT imaging, and biomarkers of atrophy and scar in macular degeneration. She has also published several book chapters on a wide variety of retinal and ophthalmic topics including diabetic retinopathy, macular hole surgery, ocular trauma, and endophthalmitis among other topics. She is an active member of the American Society of Retina Specialists, American Academy of Ophthalmology and the Association for Research in Vision and Ophthalmology.
Outside of medicine, Dr. Finn enjoys swimming, yoga, running, skiing, cooking, and hiking. She was a member of the Stanford Women's Squash Club team for four years.
Roger A. Goldberg, MD, MBA
Partner, Bay Area Retina Associates
Faculty, CPMC Ophthalmology Residency
San Francisco Bay Area, California
Roger A. Goldberg, M.D., M.B.A., a native of Boston, graduated from both college and medical school at Yale University. He completed his residency in Miami at the Bascom Palmer Eye Institute, the nation’s top eye hospital and residency-training program. He returned to Boston for a fellowship in Vitreoretinal Diseases and Surgery at Tufts and Ophthalmic Consultants of Boston. Dr. Goldberg is board certified by the American Board of Ophthalmology, and is an active member of the American Society of Retinal Specialists, the Retina Society, and the American Academy of Ophthalmology.
Dr. Goldberg has published numerous research manuscripts and book chapters, including first-author publications in The New England Journal of Medicine, Ophthalmology, JAMA Ophthalmology, and American Journal of Ophthalmology. He serves as a Reviewer for Ophthalmology, AJO and Retina, and lectures at national and international meetings. He has been an investigator in over 30 clinical trials for age-related macular degeneration, retinal vein occlusion, and diabetic retinopathy, among others. His surgical interests include macular surgery, complex retinal detachment repair and complications of cataract surgery.
Between college and medical school, Dr. Goldberg spent a year as a Rotary Scholar at the University of Leiden, The Netherlands, and then worked as a healthcare consultant at McKinsey & Co. In addition to his medical training, Dr. Goldberg received an MBA from Yale and co-founded an ophthalmic startup.
Though loyal to his Boston sports teams, Dr. Goldberg is an enthusiastic transplant to the Bay Area, where he enjoys spending time outdoors with his wife and three children.
Esther Lee Kim, MD
Vitreoretinal Surgeon Orange County Retina
Santa Ana, CA
Dr. Esther Lee Kim is a Southern California native who grew up in the Fullerton area. She received her undergraduate education at Princeton University, where she graduated cum laude with a degree in Molecular Biology. She received her medical degree from Yale University School of Medicine, where she discovered her love of ophthalmology. After her internal medicine internship at Cedars-Sinai Medical Center in Los Angeles, she completed her ophthalmology residency at the University of Southern California (USC) Roski Eye Institute (formerly Doheny Eye Institute)/ Los Angeles County Medical Center, one of the busiest and top-ranked residency programs in the country. She then pursued a subspecialty fellowship in Vitreoretinal Surgery at the Massachusetts Eye and Ear Infirmary, Harvard Medical School in Boston, MA. There, she gained clinical and surgical expertise in diseases of the macula, retina, and vitreous.
Dr. Kim has published extensively on a wide range of innovative topics in vitreoretinal surgery that have been featured in leading ophthalmology journals. She has been invited to present her research at national and international ophthalmology meetings, and she serves as an invited reviewer for several top ophthalmology journals, including Retina. Dr. Kim’s clinical interests include macular degeneration, diabetic retinopathy, retinal tears and detachments, macular puckers and holes, and retinal imaging.
When she is not practicing retina, she enjoys spending time with her husband and son, running, yoga, spinning, and trying new restaurants.
Lisa C. Olmos de Koo, MD, MBA
Associate Professor of Ophthalmology
Subspecialty Chief, Retina Division
Program Director, Vitreoretinal Surgery Fellowship
Department of Ophthalmology
University of Washington
Sonia Mehta, MD
Assistant Professor of Ophthalmology
Thomas Jefferson University School of Medicine
Sonia Mehta, MD is an active member of the Retina Service at Wills Eye Hospital and is Assistant Professor of Ophthalmology at Thomas Jefferson University School of Medicine.
She graduated magna cum laude from Boston University and received her medical degree from Boston University School of Medicine where she was awarded the Dr. Samuel & Helen Poplack Award for Outstanding Clinical Competence and Excellence in Patient Care. Dr. Mehta completed her internship in General Surgery at the University of Pennsylvania-Presbyterian Medical Center. She performed her ophthalmology residency at the University of Pennsylvania and Scheie Eye Institute. For her dedication and excellence in teaching, she was awarded the University of Pennsylvania Department of Ophthalmology Teaching Award by the faculty and students. Dr. Mehta completed her two-year vitreoretinal surgery fellowship at Emory University where she was recognized by the Department of Ophthalmology two years in a row for outstanding clinical research.
Board certified in Ophthalmology, Dr. Mehta has authored numerous articles and book chapters on vitreoretinal diseases and has lectured and taught instructional courses at ophthalmology meetings, both nationally and abroad. She is also author of Step-Up to the USMLE Step 1, among the best-selling medical textbooks, now in its fifth edition.
Dr. Mehta has expertise in all areas of retinal surgery including macular holes, macular pucker, retinal detachment, and diabetic vitrectomy. She is actively involved as a clinical investigator in several clinical trials pertaining to age-related macular degeneration, diabetic retinopathy, retinal vein occlusions, uveitis, and vitreoretinal surgery. Dr. Mehta is a member of the American Academy of Ophthalmology, American Society of Retina Specialists, Association for Research in Vision and Ophthalmology, American Medical Association, and Pennsylvania Medical Society.
Ehsan Rahimy, MD
Vitreoretinal Disease & Surgery
Palo Alto Medical Foundation
Palo Alto, CA
Adrienne W. Scott, MD
Associate Professor of Ophthalmology
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Jayanth Sridhar, MD
Department of Ophthalmology
Bascom Palmer Eye Institute
Evolve is an approved COPE Administrator.
This course is COPE approved for .5 hour of CE credit for optometrists.
Course #: 70628-PS
Activity #: 120833
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Andrew Moshfeghi, MD, Andrew A. Moshfeghi, MD, MBA, and or spouse, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Genentech, Graybug, Novartis, Regeneron, Ocular Therapeutix, and Pr3vent. Grant/Research Support: Genentech, Novartis, and Regeneron. Stock/Shareholder: Ocular Therapeutix, Graybug, Pr3vent, Placido
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Carl Zeiss Meditec or Regeneron Pharmaceuticals, Inc.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Recommended internet speed 5Mbps+